The relationship between dietary advanced glycation end products and indicators of diabetes severity in Mexicans and non-Hispanic whites: a pilot study

References

• Ames JM. 2008. Determination of N epsilon-(carboxymethyl)lysine in foods and related systems. Ann NY Acad Sci. 1126:20–24.
   PubMed Web of Science ®Google Scholar
• Batis C, Hernandez-Barrera L, Barquera S, Rivera JA, Popkin BM. 2011. Food acculturation drives dietary differences among Mexicans, Mexican Americans, and non-Hispanic Whites. J Nutr. 141:1898–1906.
   PubMed Web of Science ®Google Scholar
• Block G. 1989. Human dietary assessment: methods and issues. Prev Med. 18:653–660.
   PubMed Web of Science ®Google Scholar
• Cai W, He JC, Zhu L, Peppa M, Lu C, Uribarri J, Vlassara H. 2004. High levels of dietary advanced glycation end products transform low-density lipoprotein into a potent redox-sensitive mitogen-activated protein kinase stimulant in diabetic patients. Circulation. 110:285–291.
   PubMed Web of Science ®Google Scholar
• CDC 2011. National diabetes fact sheet [Online]. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention. Available: http://www.cdc.gov/diabetes/pubs/pdf/ndfs_2011.pdf. Accessed 19 October 2011.
   Google Scholar
• Chao PC, Huang CN, Hsu CC, Yin MC, Guo YR. 2010. Association of dietary AGEs with circulating AGEs, glycated LDL, IL-1alpha and MCP-1 levels in type 2 diabetic patients. Eur J Nutr. 49:429–434.
   PubMedGoogle Scholar
• Goldberg T, Cai W, Peppa M, Dardaine V, Baliga BS, Uribarri J, Vlassara H. 2004. Advanced glycoxidation end products in commonly consumed foods. J Am Diet Assoc. 104:1287–1291.
   PubMed Web of Science ®Google Scholar
• Luevano-Contreras C, Garay-Sevilla ME, Wrobel K, Malacara JM, Wrobel K. 2005. Restriction in advanced glycation end products (AGEs) intake decreases oxidation markers and insulin resistance in type 2 diabetes mellitus patients. Proceeding of the 87th Endocrine Society's annual meeting.
   Google Scholar
• MDRTC 1998. Diabetes History by Michigan Diabetes Research and Training Center [Online]. Available: http://www.med.umich.edu/mdrtc/profs/documents/svi/dh20.pdf. Accessed August 2011.
   Google Scholar
• Mojtahedi MC, Plawecki KL, Chapman-Novakofski KM, McAuley E, Evans EM. 2006. Older black women differ in calcium intake source compared to age- and socioeconomic status-matched white women. J Am Diet Assoc. 106:1102–1107.
   PubMedGoogle Scholar
• Negrean M, Stirban A, Stratmann B, Gawlowski T, Horstmann T, Gotting C, . 2007. Effects of low- and high-advanced glycation endproduct meals on macro- and microvascular endothelial function and oxidative stress in patients with type 2 diabetes mellitus. Am J Clin Nutr. 85:1236–1243.
   PubMed Web of Science ®Google Scholar
• Pabon-Nau LP, Cohen A, Meigs JB, Grant RW. 2010. Hypertension and diabetes prevalence among U.S. Hispanics by country of origin: the National Health Interview Survey 2000–2005. J Gen Intern Med. 25:847–852.
   PubMed Web of Science ®Google Scholar
• Rosenzweig JL, Weinger K, Poirier-Solomon L, Rushton M. 2002. Use of a disease severity index for evaluation of healthcare costs and management of comorbidities of patients with diabetes mellitus. Am J Manag Care. 8:950–958.
   PubMed Web of Science ®Google Scholar
• Stuff JE, Garza C, Smith EO, Nichols BL, Montandon CM. 1983. A comparison of dietary methods in nutritional studies. Am J Clin Nutr. 37:300–306.
   PubMed Web of Science ®Google Scholar
• Uribarri J, Peppa M, Cai W, Goldberg T, Lu M, Baliga S, . Dietary glycotoxins correlate with circulating advanced glycation end product levels in renal failure patients. Am J Kidney Dis. 2003a; 42:532–538.
   PubMed Web of Science ®Google Scholar
• Uribarri J, Peppa M, Cai W, Goldberg T, Lu M, He C, Vlassara H. Restriction of dietary glycotoxins reduces excessive advanced glycation end products in renal failure patients. J Am Soc Nephrol. 2003b; 14:728–731.
   PubMed Web of Science ®Google Scholar
• Uribarri J, Cai W, Sandu O, Peppa M, Goldberg T, Vlassara H. 2005. Diet-derived advanced glycation end products are major contributors to the body's AGE pool and induce inflammation in healthy subjects. Ann NY Acad Sci. 1043:461–466.
   PubMed Web of Science ®Google Scholar
• Uribarri J, Cai W, Peppa M, Goodman S, Ferrucci L, Striker G, Vlassara H. Circulating glycotoxins and dietary advanced glycation endproducts: two links to inflammatory response, oxidative stress, and aging. J Gerontol A Biol Sci Med Sci. 2007a; 62:427–433.
   PubMed Web of Science ®Google Scholar
• Uribarri J, Stirban A, Sander D, Cai W, Negrean M, Buenting CE, . Single oral challenge by advanced glycation end products acutely impairs endothelial function in diabetic and nondiabetic subjects. Diabetes Care. 2007b; 30:2579–2582.
   PubMed Web of Science ®Google Scholar
• Uribarri J, Woodruff S, Goodman S, Cai W, Chen X, Pyzik R, . 2010. Advanced glycation end products in foods and a practical guide to their reduction in the diet. J Am Diet Assoc. 110:911–916e912.
   PubMed Web of Science ®Google Scholar
• Vlassara H, Cai W, Crandall J, Goldberg T, Oberstein R, Dardaine V, . 2002. Inflammatory mediators are induced by dietary glycotoxins, a major risk factor for diabetic angiopathy. Proc Natl Acad Sci USA. 99:15596–15601.
   PubMed Web of Science ®Google Scholar
• Vlassara H, Cai W, Goodman S, Pyzik R, Yong A, Chen X, . 2009. Protection against loss of innate defenses in adulthood by low advanced glycation end products (AGE) intake: role of the antiinflammatory AGE receptor-1. J Clin Endocrinol Metab. 94:4483–4491.
   PubMed Web of Science ®Google Scholar